Article

Maximizing Sterility Assurance: Sterile Hold Time Testing for Sterilized Items Used in Parenteral Drug Manufacturing

Sterile hold time depends on the sterilization wrapping system, operator performance and sterilization cycle performance. Multiple regulatory agencies discuss the need for hold time studies to be completed to support parenteral drug manufacturing.
2023-06-16

Key Takeaways:

  • Sterile hold time ensures items remain sterile until used in aseptic manufacturing.
  • EU Annex 1 and USP <1211> require validated hold times and packaging integrity.
  • Separating hold time studies from APS improves failure analysis and reduces variables.
  • Wrapping, closures and transfer methods must be validated to maintain sterility.
  • A 30-day hold time was validated with Tyvek® wrapping, enhancing flexibility and reducing reprocessing. 

Loading component...

Loading component...

Loading component...

Loading component...

Loading component...